Arcadia Biosciences, Inc. · NASDAQ:RKDA

Arcadia Biosciences — Merger or Acquisition (December 2024)

19 slides from Arcadia Biosciences's merger presentation, Dec 11, 2024

  1. Slide 1: Arcadia Biosciences & Roosevelt Resources Business Combination

    Arcadia Biosciences & Roosevelt Resources Business Combination December 2024 Filed by Arcadia Biosciences, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Arcadia Biosciences, Inc. Commissi

  2. Slide 2: Disclaimer: Forward Looking Statements

    DISCLAIMER Forward Looking Statements This Presentation contains forward-looking statements within the meaning of the safe harbor provided by Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, about

  3. Slide 3: Disclaimer: Forward Looking Statements

    DISCLAIMER Forward Looking Statements Arcadia and Roosevelt, including the combined company’s future financial condition, results of operations, strategy and plans; changes in capital markets and the ability of the combined company to finance operations in the manner expected; the risks of oil and g

  4. Slide 4: Disclaimer: Forward Looking Statements

    DISCLAIMER Forward Looking Statements INVESTORS AND SECURITY HOLDERS OF ARCADIA ARE URGED TO CAREFULLY AND THOROUGHLY READ THE REGISTRATION STATEMENT AND THE PROXY STATEMENT/PROSPECTUS, AS EACH MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, AND OTHER RELEVANT DOCUMENTS FILED BY ARCADIA WITH THE S

  5. Slide 5: Transaction overview

    Transaction overview 5 * Subject to adjustment Roosevelt equity owners will own ~90% of Arcadia’s pro forma outstanding shares. Arcadia shareholders will own ~10% of Arcadia’s pro forma outstanding shares. Arcadia Biosciences, and Roosevelt Resources have entered into a definitive securities exchang

  6. Slide 6: Arcadia's strategic review led to conclusion that business combination was best alternative

    Arcadia’s strategic review led to conclusion that business combination was best alternative for shareholders Conducted extensive evaluation of potential transactions with external advisors Discontinued CBD body care brands in Q3 2023 Monetized Resistant Starch Durum Wheat trait in Q2 2024 Sold GoodW

  7. Slide 7: Zola coconut water sales are strong and operations will continue

    Zola® coconut water sales are strong and operations will continue 7 Source: NielsenIQ ZOLA in Total Grocery Stores for Latest 13 Weeks Ending 09/28/2024 in shelf stable coconut water Zola revenues grew +55% Y/Y in Q3 2024 and +29% Y/Y on a YTD basis. Growth is primarily driven by a +68% increase in

  8. Slide 8: Post-transaction name, ownership, management and board

    COMPANY WILL CHANGE NAME NEW OWNERSHIP STRUCTURE POST TRANSACTION MANAGEMENT POST TRANSACTION BOARD OF DIRECTORS Arcadia Biosciences will combine with Roosevelt Resources through the issuance of ~12.3M shares of common stock Arcadia Biosciences, Inc. Roosevelt Resources, LP Roosevelt Resources, Inc.

  9. Slide 9: Transaction timeline

    File S-4 with Securities & Exchange Commission Schedule special meeting of Arcadia stockholders Mail proxy statement to Arcadia shareholders Special shareholders meeting to vote on transaction Closing Next steps: Transaction is expected to close in Q1 2025 or soon thereafter 9 1 2 3 4 5 TRANSACTION

  10. Slide 10: Arcadia Biosciences & Roosevelt Resources Business Combination

    Arcadia Biosciences & Roosevelt Resources Business Combination December 2024

  11. Slide 11: Management Team

    Management Team Tony Roosevelt Jr. Chief Executive Officer and Chairman of the Board Jimmy C. Hawkins President and Chief Operating Officer Jerrel Branson Chief Development and Financial Officer Paul Buckner Chief Legal Officer and Corporate Secretary A 64-year veteran of the oil and gas industry, T

  12. Slide 12: Northwest Shelf San Andres Fields & CO2 Floods

    Northwest Shelf San Andres Fields & CO2 Floods Source: Map: TX Bureau of Economic Geology & NM Bureau of Geology and Mineral Resources. Production estimates by Advanced Resources International (“ARI”) dated 2022. NM TX Oil fields producing From NW Shelf San Andres Platform Carbonate Play Denver Unit

  13. Slide 13: RR Investments to Date

    RR Investments to Date $27.1M $75.6M $82.5M 2007-2018 2019-2023 2023-Current EXPLORATION PHASE APPRAISAL PHASE DEVELOPMENT PHASE Geological & Geophysical Studies Three Exploratory H2 Wells Core Extraction Comprehensive Logging 3D Seismic Further Lease Acquisition Reservoir Assessment & Studies Nine

  14. Slide 14: CCUS EOR Project Contemplated by In-House and Third-Party Resource Studies

    CCUS EOR Project Contemplated by In-House and Third-Party Resource Studies1 Aug 2007 Feb 2008 July 2010 Mar 2012 Sept 2012 Oct 2012 April 2023 Feb 2024 Aug 2024 OIP: 71,000 boe/acre OIP: 71,000 boe/acre OIP: 77,000 boe/acre OIP:77,000 boe/acre OIP: 74,220 boe/acre OIP: 74,220 boe/acre (3D seismic) O

  15. Slide 15: Roosevelt Resources Dataset Section

    Roosevelt Resources Dataset 25 Section RR EOR CCUS Project, Yoakum County, Texas RR Horizontal Wells Core Data Logs for OIP Assessment Logs for Mapping Calibration 3D Seismic Coverage Cutting images Roosevelt Resources 25 Section CCUS EOR Project Yoakum County, Texas

  16. Slide 16: RR Googins EOR Project Phase Calibration

    RR Googins EOR Project Phase 1 Calibration Top View Side View

  17. Slide 17: CCUS EOR Project using Miscible-Ascending Dispersion

    CCUS EOR Project using Miscible-Ascending Dispersion (“MAD”) Anticipated production timing(1) 1. Will be heavily dependent on capital expenditures and timing thereof as well as CO2 availability and prices actually received for oil and gas.

  18. Slide 18: Miscible Ascending Dispersion (MAD) EOR a Better Way

    CO2 Injector Producer SIDE VIEW Reservoir is ~300 ft thick ~250 ft from Injector to Producer Impermeable Seal Impermeable Seal Producer Flowing Bottom Hole Pressure Slightly Above Miscibility (est ~ 1300 psi) Injector CO2 Injection Pressure Slightly Below Pre-frac pressure point (est. ~ 3,300 – 3,50

  19. Slide 19: Conclusion: Significant Opportunity in Safe Operating Environment

    Conclusion Significant Opportunity in Safe Operating Environment Science–CO2 EOR is proven technology in San Andres Development will be accomplished in phases as development occurs Unitization is in process Project has been significantly De-risked – San Andres oil in many other nearby CO2 EOR projec

Arcadia Biosciences — Merger or Acquisition (December 2024) on 6ix